Speaker

Pedro Lichtinger, MBA

CHAIRMAN & CEO, STARTON THERAPEUTICS
Paramus, New Jersey, United States
An industry executive with a 37-year career in biotechnology and a proven track record of developing turnaround and financing strategies, executing strategic alliances, and building commercial and R&D capabilities.

He is the former President and CEO of Asterias Biotherapeutics and Optimer Pharmaceuticals with 16 years’ experience at Pfizer Inc as President of Global Primary Care and President of Europe.

He currently serves on the Advisory Board of Zero Gravity. He holds an MBA degree from Wharton School of Business and an engineering degree from the National University of Mexico.
Speaking In
[Available On-Demand]
2020 BIO Investor Forum Buzz of BIO Finalist Starton is a clinical-stage biotechnology company…